Trial Design Solutions

  1. Central Nervous System Drug Development 3/4/2021

    Our expert central nervous system (CNS) teams have extensive experience and strong knowledge of the challenges expected when implementing and mitigating CNS clinical trials.

  2. GMO Solutions 6/27/2023

    Novotech initiated the first national, privately owned, commercial Institutional Biosafety Committee (IBC) in Australia, successfully accredited by the Australian Office of the Gene Technology Regulator (OGTR).

  3. Kayentis Media Player: For Informed And Engaged Patients In Clinical Trials 6/23/2022

    Learn how the Kayentis Media Player (KMP) allows relevant information to be provided regularly through very user-friendly technology.

  4. Get It Right The First Time: Strategic Clinical Development 9/20/2023

    Start early and get it right the first time. Course correct with a changing landscape. Overcome obstacles within clinical development. Collaborate with the best strategists and problem-solvers in clinical development.

  5. NextGen Participant Engagement Platform 11/16/2023

    Uncover how the GreenSpace platform can address delays in trial timelines by overcoming insufficient recruitment and retention efforts.

  6. Diversity In Intelligent Trials 2/17/2023

    Medidata AI’s Intelligent Trials solution provides insights that allow you to take action to improve study diversity during the planning stages.

  7. Signant SmartSignals® Advisory 5/15/2024

    Safeguard protocol and endpoint data integrity with our expert support. Increase confidence, reduce workloads, and minimize risks in data quality across all trial phases and designs. Improve consistency and decrease data variability.

  8. IQVIA Biotech Virtual Clinical Trials 3/4/2021

    IQVIA Biotech virtual trials speed recruitment, heighten retention, and improve data quality by leveraging our transformative technology, unparalleled data, and  therapeutic expertise. With experience designing and delivering complex hybrid studies and 100% virtual trials across the United States, Europe and Asia, IQVIA Biotech helps emerging biopharma and biotech customers accelerate timelines and achieve study goals.

  9. Bringing Endocrine And Metabolic Disease Treatments To Market 9/20/2023

    Metabolic and endocrine diseases are a rising therapy area focus for clinical research due to the high demand for novel therapies that are challenged with proving safety and efficacy.

  10. First In Human (FIH) Fact Sheet 1/26/2023

    Altasciences has decades of experience designing, conducting, and reporting on first-in-human (FIH) clinical trials. For small or large molecules, simple or complex trials, we have the expertise, purpose-built Phase 1 facilities, and seamless processes to deliver quality with speed and ease.